Evening Standard
UK · 14 mins ago
AstraZeneca ditches lung cancer treatment trial
The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.
Do you trust Evening Standard?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!